Gnosis Health Raises £1.1 Million in Seed Funding
Gnosis Health, a Newcastle-based health intelligence company specializing in multi-disease personalized care, has successfully raised £1.1 million in a seed funding round. The investment, announced on June 2, 2026, saw participation from Innovate UK, SFC Capital, and Northstar Ventures.
Company Background
Founded by Edward Meinert and Jerrell Schivers, Gnosis Health operates from Newcastle Helix in the United Kingdom. The company focuses on leveraging health intelligence to provide personalized care solutions for multiple diseases, aiming to enhance patient outcomes through innovative technological applications.
Edward Meinert, Co-Founder and CEO, commented on the funding round, stating, "This investment marks a significant milestone for Gnosis Health as we continue to develop our platform to better serve patients and healthcare providers."
Investors and Their Role
The seed round did not name a lead investor, but it includes notable contributions from Innovate UK, SFC Capital, and Northstar Ventures. These investors are known for supporting early-stage businesses with high growth potential, particularly in the tech and healthcare sectors.
Planned Use of Funds
Gnosis Health plans to utilize the newly secured funds to enhance its platform capabilities and expand its team. The company aims to accelerate the development of its health intelligence solutions, focusing on improving the personalization of care for various diseases. Additionally, the funding will support efforts to broaden their market reach and increase collaborations with healthcare providers.
Looking Ahead
With this funding injection, Gnosis Health is well-positioned to advance its mission of transforming healthcare delivery through personalized, data-driven solutions. The company's strategic focus remains on innovation and expanding its influence within the healthcare industry.
Jerrell Schivers, Co-Founder and CTO, added, "We are excited to leverage this funding to advance our technology and bring more personalized healthcare solutions to the market."